BLSM · Forms 3, 4, 5
Insider trades at BlossomHill Therapeutics, Inc.
6 insiders bought $25.2M of BlossomHill Therapeutics, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for BlossomHill Therapeutics, Inc. (BLSM) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Carl L Gordon | Director | Conversion | 1,039,996 | Form 4 | |||
| Carl L Gordon | Director | Conversion | 1,049,283 | Form 4 | |||
| Carl L Gordon | Director | Buy | 625,000 | $16.00 | $10M | Form 4 | |
| ORBIMED ADVISORS LLC | Director | Conversion | 1,039,996 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Conversion | 1,049,283 | Form 4 | |||
| ORBIMED ADVISORS LLC | Director | Buy | 625,000 | $16.00 | $10M | Form 4 | |
| John P. Schmid | Director | Buy | 6,000 | $16.00 | $96K | Form 4 | |
| Carl L Gordon | Director | Options or other derivatives | Form 4 | ||||
| Bihua Chen | Director | Conversion | 1,599,993 | Form 4 | |||
| Bihua Chen | Director | Conversion | 1,701,541 | Form 4 | |||
| Bihua Chen | Director | Buy | 312,500 | $16.00 | $5M | Form 4 | |
| Sundeep Agrawal | Director | Conversion | 578,524 | Form 4 | |||
| Jason A Keyes | Chief Financial Officer | Buy | 700 | $16.00 | $11K | Form 4 | |
| Vincent Paul Liptak | General Counsel | Buy | 2,200 | $16.00 | $35K | Form 4 | |
| Vincent Paul Liptak | General Counsel | Conversion | 22,687 | Form 4 | |||
| Geoffrey Raymond Oxnard | Chief Medical Officer | Options or other derivatives | Form 4 | ||||
| Yishan Li | Executive Chairman | Conversion | 1,600,682 | Form 4 | |||
| Yishan Li | Executive Chairman | Conversion | 113,435 | Form 4 | |||
| Yishan Li | Executive Chairman | Conversion | 124,779 | Form 4 | |||
| Jingrong Jean Cui | President and CEO | Conversion | 1,600,682 | Form 4 | |||
| Jingrong Jean Cui | President and CEO | Conversion | 113,435 | Form 4 | |||
| Jingrong Jean Cui | President and CEO | Conversion | 124,779 | Form 4 | |||
| Vincent Paul Liptak | General Counsel | Buy | 2,500 | $15.80 | $40K | Form 4 | |
| ORBIMED ADVISORS LLC | Director | Became an insider (Form 3) | Form 3 | ||||
| John P. Schmid | Director | Became an insider (Form 3) | Form 3 | ||||
| Sheila Gujrathi | Director | Became an insider (Form 3) | Form 3 | ||||
| Sundeep Agrawal | Director | Became an insider (Form 3) | Form 3 | ||||
| Carl L Gordon | Director | Became an insider (Form 3) | Form 3 | ||||
| Bihua Chen | Director | Became an insider (Form 3) | Form 3 | ||||
| Vincent Paul Liptak | General Counsel | Became an insider (Form 3) | Form 3 | ||||
| Geoffrey Raymond Oxnard | Chief Medical Officer | Became an insider (Form 3) | Form 3 | ||||
| Jason A Keyes | Chief Financial Officer | Became an insider (Form 3) | Form 3 | ||||
| Yishan Li | Executive Chairman | Became an insider (Form 3) | Form 3 | ||||
| Jingrong Jean Cui | President and CEO | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.